Galiba G Rahman, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 7 carriers
- Office
- 1
- Since medical school
- 39 years
- Graduated 1987
Offices
1 location
Plans that list them
26 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rahman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A67092 · Current
Licensed to practise in California · since 1998 · expires 2028-07-31 · Dibrugarh University, Assam Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$13,696
Pharmacies billed $13,696 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 272) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
256 generic and 16 brand-name prescriptions · $13,696 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amlodipine Besylate | 42 | $292 | $7 |
| Metoprolol | 16 | $238 | $15 |
| Losartan | 17 | $229 | $13 |
| Metformin | 14 | $175 | $13 |
| Atorvastatin | 29 | $173 | $6 |
See all 6 drugs
| Amlodipine Besylate | 42 | $292 | $7 |
| Metoprolol | 16 | $238 | $15 |
| Losartan | 17 | $229 | $13 |
| Metformin | 14 | $175 | $13 |
| Atorvastatin | 29 | $173 | $6 |
| Glipizide | 12 | $94 | $8 |
Year by year
| 2024 | 272 | 32 | 0% (0) | 6% | $13,696 |
| 2023 | 223 | 38 | 0% (0) | None | $9,600 |
| 2022 | 316 | 45 | 0% (0) | 4% | $9,383 |
| 2021 | 327 | 48 | 0% (0) | None | $11,187 |
| 2020 | 261 | 35 | 0% (0) | 10% | $11,418 |
| 2019 | 170 | 22 | 0% (0) | None | $5,070 |
| 2018 | 118 | 17 | 0% (0) | None | $7,589 |
| 2017 | 75 | 12 | None | None | $2,944 |
| 2016 | 65 | 13 | 0% (0) | None | $1,792 |
| 2015 | 25 | None | None | None | $1,602 |
| 2014 | 22 | None | None | None | $555 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Amlodipine Besylate | 35 | $399 | $11 |
| Levothyroxine | 14 | $338 | $24 |
| Atorvastatin | 30 | $321 | $11 |
| Lisinopril | 20 | $311 | $16 |
2022: 8 drugs
| Atorvastatin | 50 | $791 | $16 |
| Metformin Hcl Er | 11 | $328 | $30 |
| Lisinopril | 30 | $288 | $10 |
| Amlodipine Besylate | 33 | $240 | $7 |
| Losartan | 18 | $213 | $12 |
| Metformin | 18 | $182 | $10 |
| Simvastatin | 13 | $137 | $11 |
| Glipizide | 11 | $83 | $8 |
2021: 8 drugs
| Atorvastatin | 49 | $550 | $11 |
| Ezetimibe | 12 | $519 | $43 |
| Losartan | 17 | $242 | $14 |
| Metformin Hcl Er | 14 | $200 | $14 |
| Lisinopril | 19 | $171 | $9 |
| Simvastatin | 21 | $120 | $6 |
| Glipizide | 11 | $108 | $10 |
| Amlodipine Besylate | 19 | $85 | $4 |
2020: 4 drugs
| Atorvastatin | 33 | $603 | $18 |
| Metformin | 16 | $181 | $11 |
| Simvastatin | 20 | $97 | $5 |
| Amlodipine Besylate | 11 | $75 | $7 |
2019: 5 drugs
| Atorvastatin | 12 | $279 | $23 |
| Simvastatin | 23 | $211 | $9 |
| Lisinopril | 11 | $163 | $15 |
| Metoprolol | 13 | $142 | $11 |
| Losartan-Hydrochlorothiazide | 11 | $106 | $10 |
2018: 1 drug
| Metoprolol | 17 | $132 | $8 |
2016: 1 drug
| Metoprolol | 12 | $47 | $4 |
Money from drug and device companies
$150 in 2019
A payment is not proof that care is biased.
| Comsort | Pneumovax 23 | $150 | 1 payment
|
See the published payment
| Comsort | Consulting · 2019-01-18 | Pneumovax 23 | $150 |
Professional record
- NPI
- 1023157187
- Licence
- CA A67092California A67092: Current · expires 2028-07-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 200 Jose Figueres Ave, Ste 260, San Jose, CA, 95116
- NPI first listed
- 2007-02-05
- NPI last updated
- 2016-06-11
This is when the NPI record was last certified, not a medical board exam.